Search
OXI-4503
go.drugbank.com/drugs/DB05143InvestigationalOXI-4503 (combretastatin A1 di-phosphate / CA1P) is a unique and highly potent, dual-mechanism vascular disrupting agent (VDA). … addition, however, preclinical data demonstrates that OXI-4503 is metabolized by oxidative enzymes (e.g., tyrosinase and peroxidases), which are elevated in many solid tumors and tumor infiltrates, to an
NS-3728
go.drugbank.com/drugs/DB05835ExperimentalNS3728 is an orally active chloride channel blocker for the treatment of cancer.
FavId
go.drugbank.com/drugs/DB05249InvestigationalFavId, is an active immunotherapy that is based upon unique genetic information extracted from a patient's tumor.
Budiodarone
go.drugbank.com/drugs/DB05519InvestigationalBudiodarone (ATI-2042) is an antiarrhythmic related to amiodarone that is currently being studied in clinical trials.
ATX-01
go.drugbank.com/drugs/DB18141InvestigationalATX-01 is an antimiR, a chemically modified antisense oligonucleotide, designed to target microRNA 23b (miR-23b).
RP-A601
go.drugbank.com/drugs/DB18339InvestigationalRP-A601 is an adeno-associated virus serotype rhesus 10 vector expressing the human galactocerebrosidase (GALC) gene
FBX-101
go.drugbank.com/drugs/DB18340InvestigationalFBX-101 is an adeno-associated virus serotype rhesus 10 vector expressing the human galactocerebrosidase (GALC) gene
ALLO-715
go.drugbank.com/drugs/DB18640InvestigationalALLO-715 is an allogeneic chimeric antigen receptor T Cell therapy targeting B cell maturation antigen (BCMA).
Tocofibrate
go.drugbank.com/drugs/DB19752ExperimentalTocofibrate has a monoisotopic molecular weight of 626.41 Da.
Nicofibrate
go.drugbank.com/drugs/DB19916ExperimentalNicofibrate has a monoisotopic molecular weight of 305.08 Da.